Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
NT$ 23.1
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very poor margins and returns
Data is available to registered users only
Data is available to registered users only
About
Labturbo Biotech Corp. engages in the technological innovation. Its Products include AIO SP-qPCR Automation System, Liquid Handling PCR Setup System and DNA/RNA Extractor Compact Systems. The company was founded on June 12, 2019 and is headquartered in Taipei, Taiwan.
Company Valuation
Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers.
Data is available to registered users only
Buy
Sell